- Forums
- ASX - By Stock
- NEU
- Ann: P2 trial shows significant improvements in Phelan-McDermid
Ann: P2 trial shows significant improvements in Phelan-McDermid, page-42
-
-
- There are more pages in this discussion • 169 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.24 |
Change
-0.240(1.55%) |
Mkt cap ! $1.940B |
Open | High | Low | Value | Volume |
$15.20 | $15.33 | $15.02 | $3.870M | 254.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 471 | $15.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.25 | 652 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 82 | 15.210 |
19 | 1024 | 15.200 |
7 | 640 | 15.190 |
9 | 1733 | 15.180 |
7 | 711 | 15.170 |
Price($) | Vol. | No. |
---|---|---|
15.220 | 434 | 14 |
15.230 | 1853 | 11 |
15.240 | 704 | 7 |
15.250 | 941 | 7 |
15.260 | 374 | 3 |
Last trade - 13.14pm 22/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online